OKYO News and Press, OKYO Pharma Limited From 04/04/23

2023-04-04 04:38:40 ET Ophthalmology-focused bio-pharmaceutical company, OKYO Pharma ( NASDAQ: OKYO ) i ntends to delist from LSE or London Stock Exchange. The delisting will have no impact on the company’s ADSs which are traded on Nasdaq. The reason for delisti...

LONDON and NEW YORK, April 04, 2023 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO; LSE: OKYO) (" OKYO " or the " Company "), an ophthalmology-focused bio-pharmaceutical company which is developing OK-101 to treat dry eye disease to address the significant unmet need in this multi-...

LONDON and NEW YORK, March 29, 2023 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO; LSE: OKYO) (“OKYO” or the “Company“), an ophthalmology-focused bio-pharmaceutical company which is developing OK-101 to treat dry eye disease (“DED“) to address the...

(NewsDirect) By David Willey, Benzinga Drug development isn’t known for being fast-paced, and developing any new drug is generally a long process. However, OKYO Pharma Ltd. (NASDAQ: OKYO) is moving quickly to develop its eye treatment drug, OK-101. It plans to begin trials for ...

2023-03-24 06:35:35 ET Okyo Pharma ( NASDAQ: OKYO ) said Panetta Partners, an entity in which the company's Executive Chairman Gabriele Cerrone has a beneficial interest, bought 10K ADSs at US$1.40 per ADS (American depositary shares). The ADSs would be equivalent to ...

LONDON and NEW YORK, March 24, 2023 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO; LSE: OKYO) (“OKYO” or the “Company“), an ophthalmology-focused bio-pharmaceutical company which is developing OK-101 to treat dry eye disease (“DED“) to address the...

2023-03-16 10:19:06 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Okyo Pharma (NASDAQ: OKYO ) stock is on the rise Thursday as investors react to news about its Phase 2 clinical trial of OK-101 . OK-101 is the company’s drug can...

2023-03-16 09:33:00 ET When searching for penny stocks to buy or penny stocks to watch, it’s good to focus on catalysts. Typically valued under $5 per share, these stocks generally attract small and new investors. Even with the glitz and glamour that comes with massive breakouts,...

LONDON and NEW YORK, March 16, 2023 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (LSE: OKYO; NASDAQ: OKYO), an ophthalmology-focused bio-pharmaceutical company which is developing OK-101 to treat dry eye disease (DED) to address the significant unmet need in this multi-billion-dollar market, today ann...

2023-03-14 09:54:11 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Uber (NYSE: UBER ) stock and Lyft (NASDAQ: LYFT ) stock are on the rise Tuesday after a court ruled that the companies’ drivers are contractors . ...